Medifast Inc
NYSE:MED
Intrinsic Value
Medifast, Inc. engages in the provision of healthy living products and programs. [ Read More ]
The intrinsic value of one MED stock under the Base Case scenario is 63.62 USD. Compared to the current market price of 33.45 USD, Medifast Inc is Undervalued by 47%.
Valuation Backtest
Medifast Inc
Run backtest to discover the historical profit from buying and selling MED stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Medifast Inc
Current Assets | 224m |
Cash & Short-Term Investments | 150m |
Receivables | 8.7m |
Other Current Assets | 65.3m |
Non-Current Assets | 85.9m |
PP&E | 67.1m |
Other Non-Current Assets | 18.8m |
Current Liabilities | 92.3m |
Accounts Payable | 86.4m |
Accrued Liabilities | 5.9m |
Non-Current Liabilities | 16.1m |
Other Non-Current Liabilities | 16.1m |
Earnings Waterfall
Medifast Inc
Revenue
|
1.1B
USD
|
Cost of Revenue
|
-296.2m
USD
|
Gross Profit
|
775.9m
USD
|
Operating Expenses
|
-649.4m
USD
|
Operating Income
|
126.4m
USD
|
Other Expenses
|
-27m
USD
|
Net Income
|
99.4m
USD
|
Free Cash Flow Analysis
Medifast Inc
MED Profitability Score
Profitability Due Diligence
Medifast Inc's profitability score is 74/100. The higher the profitability score, the more profitable the company is.
Score
Medifast Inc's profitability score is 74/100. The higher the profitability score, the more profitable the company is.
MED Solvency Score
Solvency Due Diligence
Medifast Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
Medifast Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MED Price Targets Summary
Medifast Inc
According to Wall Street analysts, the average 1-year price target for MED is 38.25 USD with a low forecast of 35.35 USD and a high forecast of 42 USD.
Ownership
MED Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
MED Price
Medifast Inc
Average Annual Return | 5.9% |
Standard Deviation of Annual Returns | 54.7% |
Max Drawdown | -90% |
Market Capitalization | 364.5m USD |
Shares Outstanding | 10 895 600 |
Percentage of Shares Shorted | 37.11% |
MED News
Last Important Events
Medifast Inc
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Medifast Inc
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Medifast, Inc. engages in the provision of healthy living products and programs. The company is headquartered in Owings Mills, Maryland and currently employs 984 full-time employees. The firm's operations are conducted through its subsidiaries Jason Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Medifast Franchise Systems, Inc., Seven Crondall Associates, LLC, Corporate Events, Inc., OPTAVIA (Hong Kong) Limited, OPTAVIA (Singapore) PTE. LTD and OPTAVIA Health Consultation (Shanghai) Co., Ltd. The firm's product line includes approximately 137 consumable options, including, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company, through Medifast Direct, its direct-to-consumer business unit.
Contact
IPO
Employees
Officers
The intrinsic value of one MED stock under the Base Case scenario is 63.62 USD.
Compared to the current market price of 33.45 USD, Medifast Inc is Undervalued by 47%.